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ABSTRACT 
The nonstructural N-terminal protease (NPro) of the pestiviruses 
possesses autocatalytic activity that cleaves itself f ram the remainder of the 
viral polyprotein. The function of NPro in virus replication and the catalytic unit 
responsible for self-cleavage have not been determined. NPro nucleotide 
sequence was obtained from Genbank or by sequence analysis for 5 isolates 
of each of the following pestiviruses: classical swine fever virus, border 
disease virus, bovine viral diarrhea virus type 1, and bovine viral diarrhea 
virus type 2. The NPro sequences of all 20 isolates were compared and 
conserved amino acid residues were identified. A conserved Gly-Ser-Asp-Gly 
motif was identified in Npro that resembles the Gly-Asp-Ser-Gly active site 
motif of serine proteases. Site-directed mutagenesis of conserved regions of 
the bovine viral diarrhea virus strain 890 NPro was accomplished by PCR using 
mutagenic primers. Additional random mutations were generated by error 
prone PCR amplification. Mutated Npro sequences were cloned into 
pBluescript for T7 RNA polymerase directed transcription. Autoprotease 
activity of mutated Npro proteins was evaluated based on the presence or 
absence of a 20 kDa cleaved protein (Npro) from the 37 kDa precursor after in 
vitro translation. Mutations at amino acids Gly67, Cys69, Ser124, and Tyr129 
resulted in loss of NPro cleavage. Rumenapf et al. (1998) had previously 
viii 
reported that His49 was essential for NP10 cleavage. In this study, mutations 
at Gly67 and Cys69 may have disrupted the catalytic function of Asp68. In 
addition, the conserved motif surrounding Ser124 and prevention of cleavage 
of NP10 by mutation of Ser124 suggest that NP10 is a serine protease resembling 
chymotrypsin with a His49/Asp68/Ser124 catalytic triad. 
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GENERAL INTRODUCTION 
Introduction 
Bovine viral diarrhea virus (BVDV) is a member of the Pestivirus genus 
of the Flaviviridae family. This genus includes three viruses that infect 
livestock populations worldwide. Members of the genus include classical 
swine fever virus (CSFV) or hog cholera virus (HCV) of swine, border disease 
virus (BDV) of sheep, and BVDV of cattle. BVDV is an important pathogen of 
cattle that has been implicated in many disease processes including 
reproductive failure, respiratory disease, and enteric disease. 
Pestiviruses are enveloped viral particles about 50 nm in diameter. 
The pestivirus genome consists of positive sense, single stranded RNA that is 
12.3 kb in length for noncytopathic isolates. Cytopathic isolates have a 
genome that is about 12.5 kb in length or longer. At the 5' and 3' ends of the 
viral genome are untranslated regions, 360 to 385 nucleotides and 186 to 229 
nucleotides in length, respectively. The pestivirus genome undergoes cap-
independent translation via an internal ribosome entry site in the 5' 
untranslated region. The genome encodes one open reading frame that is 
translated into a polyprotein of nearly 4000 amino acid residues. This 
polyprotein is processed co- and posttranslationally by viral-encoded and host 
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cell proteases resulting in 11 to 12 mature proteins: NPro, C, Erns, E1, E2, p7, 
NS2/3 (or NS2 and NS3), NS4A, NS4B, NS5A, and NS5B. 
BVDV has been divided into two biotypes, noncytopathic and 
cytopathic, based upon its effect on cultured cells. In addition, BVDV can be 
separated into genotypes BVDV1 and BVDV2. BVDV1 has been further 
divided into subgenotypes BVDV1 a and BVDV1 b. Sequence variations in 
the 5' untranslated region are used to group viral isolates into genotypes and 
subgenotypes. 
The first translated product of the pestivirus genome is NPro, which has 
autoproteolytic activity. This protein cleaves itself from the remainder of the 
viral polypeptide, although the purpose of its release and its role in replication 
are unknown. The Npro occurs only in pestiviruses and has no counterpart in 
other members of the Flaviviridae family. Previous studies have determined 
the cleavage site of Npro of CSFV by sequencing the N-terminal end of the 
adjacent downstream encoded C protein. A conserved region immediately 
upstream of the cleavage site was found among all pestiviruses, indicating 
that auto-catalytic cleavage by Npro occurred at the same site for all 
pestiviruses. Comparisons of cellular and viral-encoded proteases with NPro 
identified some sequence homology between papain-related cysteine 
proteases and NPro. In previous experiments, some conserved amino acids 
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were mutated to identify catalytic residues associated with NPro, but the 
catalytic unit was not identified. 
Thesis Organization 
This thesis is organized in the standard format consisting of a literature 
review that is divided into five sections (clinical aspects of BVDV, molecular 
biology of BVDV, previous analysis of Npro, viral proteases, and rationale and 
research aims), materials and methods, results, discussion, general 
conclusions, and references cited. 
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REVIEW OF THE LITERATURE 
Clinical aspects of BVDV 
History 
The appearance of a highly contagious and transmissible disease of 
cattle was first reported in 1946 in New York and named virus diarrhea 
(Olafson et al., 1946). This disease was clinically characterized by fever, 
leukopenia, nasal discharge, depression, anorexia, dehydration, abortion, and 
diarrhea. Gross lesions observed in diseased cattle included ulcers and 
necrosis of the mucous membranes of the lips, cheeks, tongue, pharynx, 
esophagus, abomasum, and cecum. The disease was later found to be 
caused by a virus (Prichard et al., 1955; Schipper et al. , 1955). Since its 
discovery, bovine viral diarrhea virus (BVDV) has been implicated in many 
disease processes including reproductive failure, fetal defects, respiratory 
disease, and enteric disease (Baker, 1995). BVDV is an important cause of 
economic losses for cattle producers worldwide. 
Pestivirus genus 
BVDV is a member of the Pestivirus genus of the Flaviviridae family. 
The Flaviviridae family includes flaviviruses (viruses that induce dengue fever, 
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yellow fever, and Japanese encephalitis), pestiviruses, and hepatitis C virus. 
The pestivirus genus contains three viral groups that infect livestock 
populations worldwide. Members of this genus include classical swine fever 
virus (CSFV) or hog cholera virus (HCV) of swine, border disease virus (BDV) 
of sheep, and bovine viral diarrhea virus (BVDV) of cattle (Wengler et al., 
1995). 
Pestivirus transmission 
BVDV is transmitted between animals by inhalation or ingestion of 
infected saliva, oculonasal discharge, urine, or feces (Dufell and Harkness, 
1985). In addition, infection through semen of acutely or persistently infected 
bulls has been shown (Stober, 1984). Contaminated hypodermic needles 
may also serve as viral transmitters (Roeder and Harkness, 1986). 
Pestiviruses were originally named after the species from which they 
were first isolated, but cross-infection between species has been observed. 
BVDV can infect cattle, sheep (Carlsson, 1991 ), and swine (Carbrey et al., 
1976; Terpstra and Wensvoort, 1988). BDV and BVDV have been reported 
to infect both sheep and cattle (Dufell and Harkness, 1985). Cattle 
persistently infected (discussed below) with BVDV were reported to cause 
outbreaks of disease in sheep when placed in close contact with the sheep 
(Carlsson, 1991 ). BVDV may produce clinical signs and lesions in swine 
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similar to those observed in chronic CSFV infections in swine (Terpstra and 
Wensvoort, 1988). Swine are the only species shown to be naturally infected 
with CSFV, indicating that CSFV is species specific (Loan and Storm, 1968; 
Terpstra, 1991 ). 
Subacute infection 
It has been estimated that 70% to 90 % of BVDV infections in adult 
cattle are subclinical (Ames, 1986). These cattle may have a mild elevation 
in body temperature, leukopenia, and decrease in milk production (Moerman 
et al., 1994). These subclinical infections induce antibody production that 
confers protection from clinical disease for life. Antibody may be detected as 
early as 2 to 4 weeks after infection. However, these antibodies do not 
protect the fetus from infection. The absence of clinical signs in a pregnant 
dam does not indicate fetal protection, as BVDV has been shown to cross the 
placenta and infect the fetus with nearly 100% efficiency (Duff ell and 
Harkness, 1985). Consequences of fetal infection are described below. 
Acute infection 
Disease caused by BVDV infection is usually mild and relatively brief. 
The virus has been shown to replicate primarily in the upper respiratory tract 
and lymphoid tissue (Bolin, 1990). An incubation period of 5 to 7 days 
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precedes the onset of clinical signs (Duffell and Harkness, 1985). Viremia is 
usually detected 4 to 5 days post-inoculation and may persist for up to 15 
days (Brownlie et al., 1987; Duffell and Harkness, 1985). Clinical signs 
include depression, fever, anorexia, nasal and ocular discharge, and diarrhea. 
Decreased lymphocyte numbers (Bolin et al., 1985b; Markham and 
Ramnaraine, 1985; Roth et al., 1986), and decreased neutrophil (Roth et al.,· 
1981) and monocyte (Ketelsen et al., 1979) function also has been reported. 
Oral erosions have been observed on occasion. BVDV infection has been 
shown to stimulate production of high titres of neutralizing antibodies (Donis 
et al., 1988; Bolin et al., 1991 a) which peak 8-10 weeks after inoculation 
(Nettleton and Entrican, 1995). These antibodies can persist for years and 
provide protection from disease and reinfection (Baker, 1995; Howard et al. , 
1989, 1994; Potgieter, 1995). lmmunosuppression has been reported during 
BVDV infection. The speculated result of this immunosuppression is an 
exacerbation of a secondary infection caused by parainfluenza virus type 3 
(Pl-3), infectious bovine rhinotracheitis (IBR) virus, coronavirus, rotavirus, 
Pasteurella spp., Salmonella spp., or coccidia (Baker, 1987). 
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Persistent infection 
BVDV is divided into two biotypes based on its effect on cell culture: 
noncytopathic and cytopathic (Lee and Gillespie, 1957; Gillespie et al., 1960). 
Noncytopathic BVDV accounts for more than 90% of BVDV infections in 
cattle, and is considered to be the "standard" biotype for BVDV (Dubovi, 
1992). Infection of pregnant cattle by BVDV may induce fetal death (Cassaro 
et al., 1971; Done et al., 1980; Duff ell and Harkness, 1985; Kendrick, 1971 ), 
abortions (Ames, 1986; Gillespie et al., 1967; Stober, 1984; Ward et al., 
1969), stillbirths (Woodard, 1994), congenital defects (Brown et al., 1973, 
197 4, 1975; Cassaro et al., 1971; Done et al., 1980; Duffel I and Harkness, 
1985; Wilson et al., 1984), the birth of small, underweight calves, or the birth 
of persistently infected (Pl) young (McClurkin et al., 1984; Straver et al., 
1983), depending on the viral strain and the stage of gestation when infection 
occurs. Infection of the fetus with a cytopathic BVDV may result in stillbirth 
or birth of a calf with antibody against BVDV (Brownlie et al., 1989; Duffel! 
and Harkness, 1985). Infection of a fetus during the first 120 days of 
gestation with a noncytopathic BVDV strain can result in the birth of a 
persistently infected animal (McClurkin et al., 1984). Pl animals are 
immunotolerant to the infecting strain, continually shed virus, and do not 
produce neutralizing antibodies to the infecting strain (Houe and Meyling, 
1991; McClurkin et al., 1984; Moerman et al., 1993; Taylor et al., 1997). 
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Some Pl calves may be born weak and have slow growth rates, while other Pl 
calves appear healthy (Barber et al., 1985; Coria and McClurkin, 1978; Cutlip 
et al., 1980). 
Mucosal disease 
Mucosa! disease is a lethal manifestation induced by BVDV virus, 
resulting from superinfection of a Pl calf with a cytopathic BVDV (Bolin et al. , 
1985a; Brownlie et al., 1984; Moennig et al., 1990). Although similar clinical 
signs exist in both viral diarrhea and mucosa! disease, there are distinct 
differences. Viral diarrhea is a disease characterized by mild to moderate 
clinical signs with high morbidity and low mortality rates. However, mucosal 
disease is characterized by severe clinical signs of enteric disease with low 
morbidity and high mortality rates. Initial studies reported extensive lesions 
of the oral cavity, Peyer's patches, colon, and mucosa that ultimately lead to 
death (Ramsey and Chivers, 1953). 
Hemorrhagic disease 
Hemorrhagic disease is reported to be another consequence of BVDV 
infection. Infection by virulent noncytopathic BVDV causes severe disease 
and has been implicated in outbreaks in the United States (Corapi et al., 
1989; Rebhun et al., 1989), Canada (Carman et al., 1998; Pellerin et al., 
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1994) and Great Britain (David et al., 1994). Clinical signs include fever, 
pneumonia, diarrhea, and sudden death in cattle of all ages (Carman et al., 
1998). Multiple ulcerations of the oral cavity, intestinal mucosa, upper 
alimentary tract, esophagus and rumen were reported. Experimental 
reproduction of this disease in calves has been performed and the clinical 
signs observed included fever, diarrhea, depression, leukopenia, 
lymphopenia, neutropenia, and thrombocytopenia (Bolin and Ridpath, 1992; 
Ellis et al., 1998). 
Molecular biology of BVDV 
Virion and genome 
The Pestiviruses are enveloped viral particles about 50 nm in diameter. 
The genome consists of positive sense, single stranded RNA 12.3 kb in 
length for noncytopathic isolates (Deng and Brock, 1992; Ishikawa et al., 
1995; Meyers et al., 1989a; Moormann et al., 1996) and 12.5 kb in length or 
longer for cytopathic isolates (Collett et al., 1988a; DeMoerlooze et al., 1993; 
Renard et al., 1985; Roath and Berry, 1997). The difference in lengths is 
attributed to inserts in the nonstructural protein NS3 of the cytopathic viruses 
(discussed below). At the 5' and the 3' ends of the genome are untranslated 
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regions (UTR) of 360 to 385 nucleotides and 186 to 229 nucleotides in length, 
respectively (Collett, 1992). 
BVDV genotypes 
Two genotypes of BVDV, BVDV1 and BVDV2, are recognized based 
on sequences of the 5' UTR (Pellerin et al., 1994; Ridpath et al., 1994). In 
addition, BVDV1 has been further divided into subgenotypes BVDV1 a and 
BVDV1 b (Pellerin et al., 1994; Ridpath and Bolin, 1998). Although the 5' 
UTR is the most conserved region among pestiviruses, slight sequence 
variations in the 5' UTR were used to group viral isolates into genotypes and 
subgenotypes. Previous studies have shown that antigenic differences exist 
between BVDV1 and BVDV2 isolates (Ridpath et al., 1994). These antigenic 
variations may explain why vaccination against viruses from one genotype 
does not fully protect from infection by viruses of the other genotype. BVDV1 
viruses include classical BVDV isolates used for vaccine production, 
diagnostic tests, and research as well as numerous uncharacterized field 
isolates. BVDV2 viruses are primarily recent isolates from fetal bovine sera, 
persistently infected calves born to dams vaccinated against BVDV, and 
cattle that had died from hemorrhagic syndrome (Bolin and Ridpath, 1998; 
Pellerin et al., 1994; Ridpath et al., 1994). Additionally, segregation of 
pestivirus isolates into genotypes has been accomplished by sequence 
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analysis of the N-terminal protease (Becher et al., 1997) and envelope protein 
2 (van Rijn et al., 1997). These genotype segregations are similar to ones 
based on the 5' UTR. 
Translation initiation 
Although the 5' UTR contains six AUG codons, translation does not 
start until nucleotide 386 (Collett et al., 1988a). Cell-free translation studies 
failed to demonstrate products from these small open reading frames 
(Wiskerchen et al., 1991 ). The genome is believed to be translated in a cap-
independent manner (Brock et al., 1992; Poole et al., 1995; Wiskerchen et al., 
1991 ; Rijnbrand et al., 1997). In addition, analysis of the 5' UTR of 
pestiviruses has revealed complex secondary structures comparable to those 
found in picornaviruses. Multiple AUG codons and secondary structure 
predictions indicate that the 5' UTR of Pestiviruses contains an internal 
ribosome entry site (IRES) on the 5' end of the UTR for translation initiation 
(Rice, 1996; Rijnbrand et al., 1997; Poole et al., 1995). In addition, a 
pseudoknot located immediately upstream of the translation initiation codon is 
also important for ribosome binding (Le et al., 1995). The combination of the 
IRES and the pseudoknot directs translational initiation to the authentic 
initiation codon (Rijnbrand et al., 1997). 
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Open reading frame 
The viral RNA encodes one large open reading frame, which is 
translated into a polyprotein of nearly 4000 amino acid residues. This 
polyprotein is processed co- and posttranslationally by both viral-encoded and 
host cell proteases resulting in 11 to 12 mature proteins (Stark et al., 1990; 
Wiskerchen and Collett, 1991 ; Wiskerchen et al., 1991 ). Figure 1 depicts the 
genomic organization of BVDV. In addition to the unique 5' UTR 
characteristics described above, the 3' UTR is not polyadenylated (Meyers 
and Thiel, 1996). 
The first translated product is the non-structural protein NPro, that has 
been shown to have autoproteolytic activity (Stark et al., 1993; Wiskerchen et 
al., 1991 ). This protein cleaves itself from the remainder of the viral 
polypeptide, although the purpose of its release and the role in virus 
replication are unknown. The Npro has no counterpart in other Flaviviruses. 
Studies have determined the cleavage site of the NPro of CSFV by sequencing 
the N-terminal end of the capsid protein (Stark et al., 1993). A conserved 
region among all pestiviruses is located immediately upstream of the 
cleavage site, indicating that autocatalytic cleavage by Npro occurs at the 
same site for all pestiviruses. Amino acid comparisons of NPro with cellular 
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and viral-encoded proteases have suggested that NP10 has some similarity to 
papain-related cysteine proteases (Gorbalenya et al., 1991; Stark et al., 1993; 
Wiskerchen et al. , 1991 ). 
Structural proteins 
After translation of NPro, the capsid protein (C) is translated, followed by 
three envelope glycoproteins: Ems, E1 , E2. Immediately after the C protein, 
an internal signal sequence mediates translocation of the envelope proteins 
to the lumen of the endoplasmic reticulum. The cleavage of the C protein 
from the proceeding envelope precursor protein E1ns/E1/E2 occurs upon 
translocation of the envelope precursor protein into the endoplasmic reticulum 
and is mediated by a host cell signalase (Rumenapf et al., 1993). In addition, 
the F"s/E1/E2 precursor is cleaved into Ems/E1 and E2 by a host cell 
signalase. The cleavage of Erns/E1 into E1ns and E1 is delayed. Cleavage 
site analysis of E1 revealed that a protease other than a host cell signalase 
may be required and this is likely to be the reason for the cleavage delay 
(Rumenapf et al. , 1993). The type of protease that cleaves Erns/E1 into Ems 
and E1 remains unknown . . It has been hypothesized that E1 may be 
transported into the Golgi apparatus for processing by this unknown protease 
(Rumenapf et al., 1993). 
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Envelope proteins E1 and E2 have membrane anchors that allow 
integration into the lipid envelope of the virion (Rumenapf et al., 1993; van Zijl 
et al., 1991 ), but the method of association of pns with the lipid envelope is 
unknown. All three glycoproteins form disulfide-linked complexes: Erns 
homodimer, E1-E2 heterodimer, and E2 homodimer (Thiel et al., 1991; 
Weiland et al., 1990). These complexes are assembled because cysteine 
residues in the C- terminal half of the E2 form intermolecular disulfide bonds 
with E1 or E2. Similarly, cysteine residues in the N-terminal half of E2 form 
intramolecular disulfide bonds (van Rijn et al., 1994). 
Studies have demonstrated neutralizing epitope activity of the Erns and 
E2 (Onisk et al., 1991; Weiland et al., 1990; Weiland et al., 1992; Xue et al., 
1990). In addition, Erns and E2 of CSFV induce a protective immunity in the 
host against challenge-exposure with virulent classical swine fever virus 
(Hulst et al., 1993; Konig et al., 1995; van Zijl et al., 1991 ). The E1 
glycoprotein lies buried beneath the envelope and does not induce antibody 
production (Weiland et al., 1990). 
Envelope glycoprotein pns from CSFV has been shown to have RNase 
activity (Schneider et al., 1993). Proteins with similar RNase activity have 
not been found in Flaviviruses other than the pestiviruses. A search of 
known genetic sequences revealed significant sequence similarity between 
pns and certain fungal and plant ribonucleases (Hulst et al., 1994; Schneider 
J 
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et al., 1993). Biochemical characterization of Ems revealed substrate 
specificity for uridine and zinc was found to inhibit the RNase activity of F 05 
(Schneider et al., 1993). Later studies showed that the antibodies, which 
effectively blocked the infection of cells in vitro, also exerted pns RNase 
inhibition (Windisch et al., 1996). These results suggested that Ems may have 
a vital role in the life cycle of the virus, possibly participating in RNA 
processing, although the specific function of this RNase activity with respect 
to the virus life cycle is not yet understood. 
Envelope glycoprotein E2 has been shown to induce a protective 
immune response in studies with CSFV (Hulst et al., 1993; Konig et al., 1995; 
van Zijl et al., 1991 ). Later studies showed that the N-terminal portion of E2 
is the most immunogenic portion of the glycoprotein (van Rijn et al., 1993). 
Although E2 is the most variable pestivirus gene, similarities between BVDV 
and CSFV E2 proteins were reported in cysteine residue locations and 
variable amino acid positions (Paton et al., 1992; van Rijn et al., 1994 ). 
Monoclonal antibody reactivity studies have failed to detect an E2 epitope that 
is conserved among all pestivirus strains (van Rijn et al., 1997). 
Downstream of the glycoprotein E2 is the putative p7 protein. This 
7kDa protein, although not a major structural constituent, links glycoprotein 
E2 to nonstructural protein NS2-3 in the polyprotein. Viral protein expression 
studies identified that the E2-p7 cleavage is often incomplete, giving rise to a 
18 
larger E2-p7 product. E2-p7 cleavage is believed to occur via host cell 
signalase (Elbers et al., 1996). 
Non-structural proteins 
The remainder of the Pestivirus open reading frame encodes 
nonstructural (NS) proteins. Translation of the precursor protein NS2-3 and 
its role in cytopathogenicity of the virus are discussed later. Cleavage events 
are mediated at four sites (NS3-4A, NS4A-4B, NS4B-5A, NS5A-5B) by a 
viral-encoded serine protease (Tautz et al., 1997; Wiskerchen and Collett, 
1991; Xu et al., 1997). The N-terminal end of NS3 codes for this serine 
protease, which releases itself at the C-terminal end of NS3. The NS3 is 
responsible for the release of NS4A, NS4B, NS5A, and NS5B (Wiskerchen 
and Collett, 1991 ). It was later reported that NS3 requires NS4A as a 
cofactor for cleavage at two sites: NS4B-NS5A and NS5A-NS5B (Xu et al., 
1997). In addition to serine protease activity, the NS3 also exhibits NTPase 
and helicase activity (Tamura et al., 1993; Warrener and Collett, 1995; 
Wiskerchen and Collett, 1991 ). 
NS3 and cytopathogenicity 
Experiments have shown that noncytopathic pestiviruses produce only 
the NS2-3 precursor protein (Collett et al., 1988b). Cytopathic effects of 
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pestiviruses can be attributed to cleavage of the NS2-3 precursor protein to 
yield the NS3 protein (Donis and Dubovi, 1987a,b; Greiser-Wilke et al., 1992; 
Purchio et al., 1984). NS3 production and subsequent cytopathogenicity 
have been linked to the following mutational events: insertion of cellular RNA 
sequences, duplication and rearrangement of pestivirus sequences, and large 
in-frame deletions resulting in subgenomic defective interfering (DI) RNAs 
(Meyers and Thiel, 1996). It has been hypothesized that recombinational 
events cause the integration of cellular and viral coding sequences into the 
viral genome. The newly inserted sequences that result in a cytopathic virus 
either exhibit autoprotease activity, serve as a recognition site for protease 
cleavage, or induce a conformational change in which NS2-3 cleavage occurs 
by some unknown mechanism. Cytopathic BVDV strains with cellular inserts 
probably gained the cellular sequence through template switching during the 
synthesis of viral negative strand RNA. This recombination may be guided 
by nucleotide interactions between the newly synthesized viral RNA and 
cellular or viral RNA molecules (Meyers and Thiel, 1996). 
BVDV isolate NADL was reported to contain a 270 nucleotide cellular 
insertion of bovine mRNA into the NS2-3 region (Meyers et al., 1990). A 
later study (Mendez et al., 1998) showed that deletion of this cellular insert 
(clns) from the NADL isolate genome produced viable virus particles, but 
cytopathogenicity had been abolished and NS3 protein was not detectable. 
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In addition, deletion of the clns resulted in lower levels of viral RNA synthesis, 
although virus protein and virion production was not affected. The role of 
clns in cleavage of NS2-3 is not known (Mendez et al., 1998). 
Another intriguing association is the cellular insert of light chain 3 of 
microtubule-associated proteins 1 A and 1 B into the NS2-3 of cytopathic 
BVDV strain JaCP (Meyers et al., 1998). An insertion of light chain 3 
sequence, flanked by viral duplicated elements was able to induce cleavage 
of NS3. Both insertion of light chain 3 and viral duplications were necessary 
to produce viable virus particles (Meyers et al., 1998). In a separate study, 
cytopathic BVDV strain CP7 was found to contain a 27 nucleotide viral 
duplication in its NS2-3. Experimental deletion of this duplicated viral 
sequence resulted in the loss of NS2-3 cleavage (Tautz et al., 1996). 
BVDV isolates have been reported to contain ubiquitin inserts. A 228 
nucleotide insertion in BVDV Osloss was found to encode a complete copy of 
ubiquitin (Meyers et al., 1989b). A study of BVDV isolate CP1 revealed a 
366 nucleotide insertion composed of a complete ubiquitin gene plus a 
truncated portion of a ubiquitin gene embedded in a 2384 nucleotide viral 
duplication (Meyers et al., 1991 ). The in-frame insertion of ubiquitin 
upstream of the NS3 protein provides a processing site for cellular ubiquitin 
carboxyl-terminal hydrolase to release the NS3 protein. 
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Cytopathic BVDV strains Pe515CP and CP6 were found to contain 
viral inserts as well as vi ral sequence duplications. The viral insert for both 
isolates was found to be NPro. For isolate Pe515CP, the Npro was missing the 
first 14 N-terminal amino acids, while isolate CP6 contained a complete Npro 
coding sequence. Both NPro inserts were flanked by large duplicated viral 
sequences derived from the NS2-3 encoding region. The large duplicated 
regions of Pe515CP and CP6 were found to be 2304 and 3635 nucleotides, 
respectively. The NPro of both of these isolates was functional , resulting in 
autoproteolytic removal of itself from the NS2-3 region and generating the 
amino terminus of the NS3. Despite the absence of the first 14 amino acids 
of the Pe515CP Npro insert, the protease retained its autoproteolytic activity 
(Meyers et al. , 1992). 
The frequent association of the N-terminus of the NS3 protein as a 
target for nonhomologous recombination has lead to speculation that this site 
may be highly prone to recombination (Meyers and Thiel, 1996). A recent 
study found the contrary. Viral RNA was extracted from BVDV infected cells 
and sequenced. Results demonstrated that recombination events had 
occurred at many different genomic locations (Desport et al., 1998). Thus, 
clustering of recombinational events at the N-terminal end of NS3 was not 
supported by this analysis. Apparently, nonhomologous recombination in 
pestiviruses is determined more by RNA secondary structure than by 
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sequence. As RNA polymerase moves along the template, it may be slowed 
by processivity of the enzyme or template secondary structure features, and 
disassociate from the template. The RNA polymerase may associate with a 
new template and continue RNA synthesis. The release of the RNA 
polymerase from the new template and the return to the original viral template 
also may be influenced by template secondary structure or polymerase 
pausing. Template switching events are likely to produce nonviable 
genomes because of frameshifts and the introduction of nonsense codons. 
The relatively high frequency of recombinational events may cause rapid 
evolution of the Pestivirus genome (Desport et al., 1998). 
An increased genome size caused by duplications and/or insertions is 
associated with cytopathic BVDV viruses. Truncated BVDV genomes have 
also been described (Kupfermann et al., 1996; Tautz et al., 1994). Truncated 
genomes are associated with defective interfering particles (DI). These Dis 
cannot replicate without the aid of a helper virus that compensates for missing 
portions of the DI truncated genome. BVDV isolate CP9 contains an 8 kb 
genome, as the result of a deletion that extends from the C-terminal end of 
the Npro through the NS2. The genome of this DI does not encode any 
structural proteins, but is packaged in the structural proteins produced by a 
noncytopathic helper BVDV. The autoproteolytic activity of NPro contained in 
the DI was shown to generate the N-terminus of the adjacent NS3, resulting 
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in cytopathogenicity (Tautz et al., 1994). A second DI particle, CP13, has 
been reported (Kupfermann et al., 1996). This DI contains two internal 
deletions that removed the structural genes NPro, p7, and NS2. Replication of 
CP13 is dependent on aid from a noncytopathic helper virus. 
Cytopathic BVDV isolates Oregon C24V and Singer were reported to 
not possess genomic alterations and were thought to generate NS3 by 
processing of the NS2-3 precursor. It was determined that the C-terminal 
portion of the NS2 and the first 66 amino acids of NS3 play a vital role in NS2-
3 cleavage. Analysis of the NS2 C-terminal ends of strains Oregon and 
Singer with respect to NS2 of other cytopathic isolates revealed single amino 
acid differences that may be responsible for cleavage of NS2-3 to generate 
NS3 without genome alteration. Nucleotide point mutations have resulted in 
these amino acid changes that may seNe as recognition sites for protease 
cleavage (Kummerer et al., 1998). 
NS4 and NSS 
The role of NS4A and NS4B in viral replication is not known. However, 
for hepatitis C virus, a member of the flavivirus family, the analogous NS4A 
seNes as a cofactor for enzymatic activity of NS3 (Rice, 1996). NSSB 
contains a characteristic amino acid sequence motif Gly-Asp-Asp, which 
indicates that it encodes for an RNA-dependent RNA polymerase (Meyers et 
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al., 1989a). Studies have shown that the NS5 protein possesses RNA-
dependent RNA polymerase activity (Tan et al., 1996). Recent studies have 
shown that NS5 of BVDV, yellow fever virus, and hepatitis C virus (all 
members of the flavivirus family) is phosphorylated by host cell 
serine/threonine kinases (Reed et al., 1998). Phosphorylation may regulate 
the subcellular localization of NS5 to the nucleus for altered host gene 
expression by the virally encoded RNA polymerase. Phosphorylated NS5 
may also enhance viral replication through interactions with NS3 or other viral 
or host proteins. Phosphorylation of NS5 has also been proposed to 
modulate the host interferon antiviral response (Reed et al., 1998). 
Previous analysis of Npro 
Because a combination of viral and host proteases are necessary to 
process the BVDV precursor into mature proteins, it is important to investigate 
the viral proteases to determine their role in the production of virions. 
Discussed below are studies that have attempted to determine the function of 
NPro, a self-cleaving protease of unknown importance in replication of 
pestivi ruses. 
The autoproteolytic activity of the NPro of pestiviruses has been 
demonstrated (Wiskerchen et al., 1991; Stark et al., 1993; Thiel et al., 1993). 
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In the earliest study, characterization studies were performed using amino 
acid mutagenesis (Wiskerchen et al., 1991 ). Here, two BVDV genome 
constructs were made and expressed, one encoding the NPro and a truncated 
C, and a second encoding the NPro, C, Ems, and E1 regions. The NPro was 
shown to cleave itself from both expressed polypeptides, indicating that 
downstream translation is not required. In addition, these results suggest 
that translation of downstream viral genes does not signal for the release of 
the Npro. 
A review of common features of viral proteases did not reveal any 
amino acid sequence similarity between the NPro of BVDV and other viral 
proteases. An earlier study showed that histidine, aspartic acid, serine, and 
cysteine were enzymatically functional amino acids commonly found in viral 
proteases (Wellinnk and van Kammen, 1988). In addition, glycine, serine, 
alanine, threonine, methionine, and valine were common N-terminal amino 
acids created by proteolytic cleavage. Citing this work, Wiskerchen et al. 
(1991) made site-directed mutations in the Npro encoding region to determine 
enzymatically active amino acids. Three mutations resulted in the loss of a 
Npro product: His40, His49, and Trp164. Mutations at amino acid residues 
Ser124, Ser169, Thr171, Glu173, Glu175, and Lys179 did not affect p20 
cleavage. Deletions were also made, ~ 111-124 and ~ 163-173, eliminating 
cleavage of the Npro. Based on these findings, they concluded that because 
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the Trp164 mutation resulted in loss of NPro function, NPro might resemble 
chymotrypsin (Wellink and van Kammen, 1988) and the alphavirus capsid 
autoproteinase (Strauss and Strauss, 1986; Strauss et al., 1987), both serine 
proteases that cleave at a Trp residue. Additionally, because the amino acid 
after Trp164 in BVDV is a Val residue, and Val was reported to be frequently 
created as an new N terminal end by viral proteases (Wellink and van 
Kammen, 1988), Val165 was predicted to be the newly created N-terminal 
amino acid of the C protein. Thus, the preliminary characterization of the NP10 
of BVDV revealed similarity to the cleavage pattern of the capsid 
autoproteinase of alphaviruses and suggested that cleavage occurred after 
Trp164 (Wiskerchen et al., 1991 ). However, the definitive protease class of 
NP10 or the cleavage site between NP10 and C were not established. 
Additional studies have been performed on the 23 kDa NP10 of CSFV, 
which is analogous to the 20 kDa NPro of BVDV (Stark et al., 1993). The NP10 
is the first protein encoded by the CSFV open reading frame, followed by the 
capsid protein (C). In previous studies, CSFV genome constructs of Npro (23 
kDa) and C (14 kDa) failed to demonstrate a 37 kDa precursor protein, 
leading to speculation that the NP10 contained autoproteolytic activity (Thiel et 
al., 1991 ). Cleavage between the NP10 and C regions was reported later, with 
NP10 possessing the autoproteolytic activity (Stark et al., 1993). 
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Studies were performed to determine the cleavage site of the Npro of 
CSFV (Stark et al. , 1993). The amino acid sequence surrounding the 
putative cleavage site of Npro contains only two Cys residues: Cys161 and 
Cys168. Depending on the actual cleavage site of Npro, Cys radiolabeling 
would reveal where cleavage occurs. If Npro cleavage occurred at Trp164, as 
had been previously assumed (Wiskerchen et al., 1991 ), both Npro and C 
would be radiolabeled in this experiment. However, if NPro cleavage occurred 
after Cys168, only Npro would be radiolabeled. In vitro translation was 
performed in the presence of [35S]Cys. Only a single translational product 23 
kDa in size was radioactively labeled, indicating that cleavage did not occur 
between Trp164 and Val165, as previously assumed. It was concluded that 
the cleavage site of NPro was located downstream from Trp164. Stop codons 
were introduced at various positions, but only stop codons downstream of 
Cys168 resulted in a 23 kDa protein that co-migrated with the native CSFV 
NPro protein. N-terminal amino acid sequencing of the capsid protein was 
also performed, revealing a serine on the N-terminal end. Based on these 
results, the cleavage event was determined to occur between the NPro and C 
proteins between residues Cys168 - Ser169. 
A recent study was conducted to identify essential amino acids for NPro 
activity (Rumenapf et al., 1998). Protease inhibitors were used to classify the 
type of protease to which Npro belonged. Serine, cysteine, and aspartic acid 
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protease inhibitors were not successful in preventing NPro cleavage, indicating 
that Npro does not belong to any of these protease types. Site directed 
mutagenesis revealed that Glu22, His49, and Cys69 were essential for 
proteolytic activity. This data confirmed a previous hypothesis that His49 
was an enzymatically important residue (Wiskerchen et al. , 1991). His130, 
which previously had been hypothesized to be an enzymatically important 
amino acid (Stark et al., 1993), did not prevent Npro cleavage when mutated. 
Mutational analysis of histidine residues His40 and His99 did not prevent Npro 
cleavage. Cysteine residues were also mutated without affecting Npro 
cleavage: Cys112, Cys134, Cys138, and Cys161. These results suggested 
that Npro was not a papain-like cysteine protease. Additionally, mutation of 
Asp68 did not prevent Npro cleavage. N-terminal deletions of Npro revealed 
that the first 21 amino acids were not essential to proteolytic function. 
Results also suggested that Glu22 was a catalytic amino acid residue, 
indicating that the association of Glu22-His49-Cys69 might represent a 
catalytic triad similar to the subtilisin-like serine proteases. 
Because the function of NPro is unknown, studies have been performed 
to determine its role in viral replication. In one study, Npro was not required 
for viral replication in cell culture (Tratschin et al., 1998). Replacement of the 
CSFV Npro with ubiquitin resulted in recombinant virus particles that were able 
to infect cell culture as well as induce anti-CSFV antibodies when inoculated 
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into pigs. Deletion of the entire NPro, but leaving an AUGGGG starting 
sequence, did not result in infectious virus. These results suggested that the 
Npro has no essential role in viral replication other than autocatalytic cleavage 
at its carboxy-terminus to generate the amino-terminus of the viral capsid 
protein (Tratschin et al., 1998). 
In another study, the BVDV Dl9c genome was found to contain the 5' 
UTR, NPro, NS3 to NS5B and the 3' UTR (Behrens et al., 1998). 
Experimental deletion of the NPro destroyed the ability of Dl9c particles to 
replicate. Replacement of the Npro with ubiquitin in-frame with the remainder 
of the DI genome also rendered the genome nonreplicative. When the N-
terminal 42 amino acids (126 nucleotides) of the Npro were fused to a ubiquitin 
gene, the adjacent NS3 was cleaved and DI RNA was able to replicate. 
These results suggested that an essential structural and functional part of the 
IRES transcription element was located within the Npro. In addition, these 
results contradicted previous data that had suggested that Npro was not 
required for viral replication (Tratschin et al., 1998). Similar IRES 
transcription cis-acting elements had been previously described from the 
flaviviruses Kunjin (Khromykh and Westaway, 1997) and hepatitis C virus (Lu 
and Wimmer, 1996). The 5' end of Npro (first 126 nucleotides) may prove to 
be a cis-acting element that is critical to viral RNA replication in BVDV 
(Behrens et al., 1998). 
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Viral proteases 
Serine proteases 
Serine proteases are characterized by a serine (Ser) residue in the 
active site. Two additional active amino acids, aspartic acid (Asp) and 
histidine (His), are highly conserved in the three largest serine protease clans 
to form a catalytic triad capable of cleaving peptide bonds (Rawlings and 
Barrett, 1994). Arrangement of amino acids in the catalytic triad separates 
the serine proteases into clans. Despite the different arrangements of amino 
acid residues in the catalytic triad, glycine (Gly) residues tend to be 
conserved around the catalytic serine in a Gly-X-Ser-Gly motif. 
Chymotrypsin-like serine proteases are secreted proteins that contain a 
His/Asp/Ser catalytic triad (Rawlings and Barrett, 1994). Subtilisin-like serine 
proteases preferentially ·cleave at aromatic residues [phenylalanine (Phe), 
tryptophan (Trp), and tyrosine (Tyr)] but will cleave a nonaromatic or charged 
side chain if a hydrophobic residue is present three or four positions upstream 
of the cleavage site. The subtilisin catalytic triad order is Asp/His/Ser 
(Rawlings and Barrett, 1994). Table 1 lists the serine protease clans and the 
amino acids that form the catalytic triads. 
The capsid shell of herpesviruses, such as cytomegalovirus (CMV), is 
assembled by proteolytic processing of scaffolding proteins within the capsid 
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core. The herpesviruses encode a protease (PR) at the N terminal end of 
their large genome that processes these scaffolding proteins. This virally 
encoded protease is highly conserved among all herpesviruses, although 
there is little sequence homology to known serine proteases. 
Cytomegalovirus protease crystal structure (Qiu et al., 1996) revealed a novel 
fold that contains an active site His/His/Ser. Structural similarities between 
the cytomegalovirus protease and chymotrypsin, a serine protease, indicate 
that the herpesvirus protease is a serine protease. 
Table 1. Serine proteases are divided into two major clans: chymotrypsin and 
subtilisin. Viral proteases that have been characterized are listed with their 
catalytic triad sequence. 
p rotease type A . "d ct1ve res1 ues 
I Chymotrypsin Clan Serine His/ Asp/Ser 
Alphavirus, Sindbis virus capsid Serine His/Asp/Ser 
Flavivirus NS3 Serine His/Asp/Ser 
Potyvirus P1 Serine His/Asp/Ser 
Arterivirus Serine His/Asp/Ser 
Herpesvirus, Cytomegalovirus PR Serine His/His/Ser 
I Subtilisin Clan Serine Asp/His/Ser 
Herpes virus 1 Serine Asp/His/Ser 
I 
I 
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Sindbis virus, an alphavirus, codes for a core protein (SCP) that 
cleaves itself from the viral polyprotein. After this autocatalytic event, the 
core protein inactivates itself by inserting its C-terminal tryptophan into the 
substrate-binding site. The core protein then assembles into an icosahedral 
core that surrounds the viral RNA. A His/Asp/Ser catalytic triad, similar to 
chymotrypsin , was discovered with an active serine residue (Tong et al., 
1993). 
The flavivirus non-structural protein NS3 cleaves non-structural 
proteins at the C terminal end of the viral polypeptide. NS3 lacks sequence 
homology with any known protease, but analysis of crystallized NS3 revealed 
a three-dimensional structure similar to chymotrypsin, with a His/Asp/Ser 
catalytic triad (Kim et al. 1996). Other members of the chymotrypsin-like 
serine protease clan include the N-terminal protease P1 of the potyviruses 
and the Nsp4 replicase processing peptidase of arteriviruses (Rawlings and 
Barrett, 1994). 
Members of the subtilisin clan of serine proteases can be grouped by 
the order of their catalytic triad: Asp/His/Ser. They also differ substantially in 
their three-dimensional structure when compared to the chymotrypsin clan. 
The only known viral member of the subtilisin-like proteases is a catfish 
herpes virus protease (Rawlings and Barrett, 1994). 
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Cysteine proteases 
Cysteine proteases that resemble the cellular enzyme papain have 
been reported for many positive stranded RNA viruses. A list of viral 
cysteine proteases and their associated catalytic units is provided in Table 2. 
Essential cysteine and histidine residues have been identified in the potyvirus 
Cl protein (Oh and Carrington, 1989), alphavirus nsP2 (Hardy and Strauss, 
1989) and coronavirus p28 (Baker et al., 1993). Two groups of cysteine 
proteases were proposed (Gorbalenya et al., 1991 ). The first group contains 
Table 2. Cysteine proteases that have been identified from viruses are listed. 
The amino acid residues involved in proteolytic activity and their sequential 
order varies. 
Protease type Active residues 
Papain Cysteine Asn/His/Cys 
Alphavirus nsP2 Cysteine Cys/His 
Adenovirus Cysteine His/Glu/Cys 
Aphthovirus L-pro Cysteine His/Cys 
Coronavirus p28 Cysteine Cys/His 
Picornavirus 2A Cysteine His/Asp/Cys 
Picornavirus 3C Cysteine His/Glu/Cys 
(His/Cys dyad?) 
Potyvirus HC-Pro Cysteine Cys/His 
Potyvirus Nia Cysteine His/Asp/Cys 
Rhinovirus 2A Cysteine His/Asp/Cys 
I 
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accessory leader proteases that autocatalytically cleave at their own C 
terminal end. Potyviruses, rhinoviruses, and aphthoviruses are members of 
this accessory leader protease group (Dougherty and Semler, 1993; 
Sommergruber et al., 1997). The second group of viral cysteine proteases 
process nonstructural proteins that aid in viral replication. These members 
include the proteases of alphaviruses, rubiviruses, and coronaviruses 
(Dougherty and Semler, 1993). 
Adenoviruses code for a cysteine protease that processes the core 
proteins within an assembled virion. The active site of this protease contains 
a His/Glu/Cys catalytic triad. An 11 amino acid peptide cofactor increases 
protease activity 300-fold by altering the active site conformation (Ding et al., 
1996). In addition, contact with viral DNA increases enzyme activity an 
additional 20-fold. 
An N-terminal autoprotease, also called leader proteinase (L-pro), is 
found in aphthoviruses, of the Picornaviridae family. This protease was 
found to be a papain-related protease by mutational analysis, with Cys-23 
and His-120 being catalytic residues (Piccone et al. , 1995a). The leader 
protease was not required for viral replication (Piccone et al., 1995b), but was 
a participant in cleavage of host cell initiation factor 4G and termination of 
host cell cap-dependent protein synthesis (Devany et al., 1988). 
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The 3C protease of picornaviruses is responsible for the cleavage of 
nonstructural proteins. The protease also has been shown to bind viral RNA 
and to aid in initiating RNA replication. Computer generated secondary 
structure predictions and structural analysis of crystallized 3C cysteine 
protease concluded that 3C resembled the serine protease chymotrypsin 
(Matthews et al. , 1994). The 3C protease shares less than 10% sequence 
homology with members of the chymotrypsin family of serine proteases 
(Bazan and Fletterick, 1988). A 3C catalytic triad of His/Glu/Cys is 
positioned similar to the His/Asp/Ser catalytic triad of serine proteases. The 
3C proteases may also utilize a weaker His/Cys catalytic dyad that is similar 
to the caspase His/Cys dyad. This protease represents a distinct group of 
cysteine proteases that structurally resembles the serine protease 
chymotrypsin. 
Rationale and research aims 
Much remains unknown about the Npro of BVDV and its autoproteolytic 
activity. The NPro may only generate the amino terminus of the adjacent 
capsid protein, or it may cleave or aid in cleavage at other sites within the 
polyprotein. It is also possible that NPro may cleave cellular proteins or 
interact with other opportunistic pathogens. The cleavage site of Npro has 
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been determined (Stark et al. , 1993) but the purpose for autocatalytic activity 
and its role in viral pathogenesis are unknown. In addition, enzymatically 
important amino acids need to be identified in order to characterize the 
protease. 
Previous studies of the Npro of BVDV (Wiskerchen et al., 1991) and 
CSFV (Stark et al. , 1993) both stated the need to classify the N- terminal 
proteases of pestiviruses. Additionally, both studies called for the 
identification of catalytic amino acids. Previously, histidine, aspartic acid, 
serine, and cysteine were identified as amino acids important for viral 
protease function (Wellink and van Kammen, 1988). Additionally, amino acid 
comparison of pestivirus Npro to other cellular and viral proteases revealed 
conserved amino acids (Stark et al., 1993). Similarities were reported 
between the pestiviral Npro and papain-like cysteine proteases (Stark et al., 
1993). 
This study compares the Npro region of BVDV type 1 and 2, CSFV, and 
BDV to other cellular and viral proteases in order to identify conserved 
regions and enzymatically active areas within Npro. Based on these 
conserved regions, mutational analysis of conserved amino acids should 
indicate enzymatically functional amino acids. In addition, this study attempts 
to characterize the Npro of BVDV by identifying its catalytic unit. 
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If the protease resembles a cysteine protease, amino acids Gly67, 
Cys69, His130 and Cys168 likely represent enzymatically functional residues 
of the Npro. Mutational substitution of these residues should destroy the 
autoproteolytic activity of the Npro autoprotease. Additional mutations made 
within conserved regions of NPro might reveal which amino acids are important 
for cleavage and establish a possible protease characterization. The 
purpose of this study is to determine the effect that mutations at amino acids 
Gly67, Cys69, His130 and Cys168 have on protease function of Npro and the 
effects of additional mutations at other sites in NPro have on cleavage of NPro 
from C. 
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MATERIALS AND METHODS 
Cells and viruses 
BVDVtype 1 isolates included: C24V (Gillespie eta/., 1960), NY-1 , 
Singer, TGAN (Bolin and Ridpath , 1992), and Van Meter (Ridpath and Bolin, 
1990). BVDV type 2 isolates included: 1373, 28508, 296nc, AZSPLN, 
Parker, and 890 (Bolin and Ridpath, 1992). BVDV type 1 and 2 isolates were 
propagated in bovine turbinate (BT) cells grown in McCoy's medium (GIBCO, 
Grand Island, NY, USA), supplemented with 10% fetal bovine serum that had 
been tested and found to be free of BVDV and BVDV antibodies (Bolin et al., 
1991 b ). BT cells were grown in 25 cm2 flasks until 80% confluent. The 
media was removed from the flask and virus was added to a concentration of 
105-106 cell culture infectious dose virus as previously described (Ridpath and 
Bolin, 1991 ). After one hour incubation, the inoculum was replaced with 
McCoy's media and the inoculated cells were incubated at 37°C for 24 
(cytopathic isolates) or 48 hours (noncytopathic isolates) before being frozen 
at -80°C for storage. BDV isolates were grown in ovine fetal turbinate 
(OFTU) cells using the same media and supplements for 48 hours. BDV 
isolates included: CB2, CB5, ldaho207, ldaho209, and ldaho211 (Ridpath, 
personal communication). BVDV and BDV isolates used for this study 
included laboratory reference strains, vaccine strains, and field strains 
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isolated from diseased cattle and sheep. All isolates had been maintained 
and stored at the National Animal Disease Center. 
RNA extraction 
Viral RNA was extracted from infected cells that were freeze/thawed 
using Catrimox-14 (Iowa Biotechnology Corp., Oakdale, IA, USA) as 
previously described (Dahle and Macfarlane, 1993). Flasks of frozen (-80°C) 
virus infected cells were thawed at room temperature and the resulting 
freeze/thaw lysate was used for viral RNA extraction. One ml of Catrimox-14 
(36 mg/ml H20), 50 µg of yeast tRNA (Life Technologies, Gaithersburg, MD, 
USA), and 400 µI of freeze/thaw cell lysate were mixed, vortexed and 
incubated for 10 minutes at room temperature. The solution was centrifuged 
at 15,000 x g for 10 minutes and the supernatant was discarded. The pellet 
was resuspended in 500µ1 of 2M LiCI and then centrifuged at 15,000 x g for 
10 minutes. The resulting pellet was washed twice with cold 75% EtOH and 
centrifuged at 15,000 x g for ten minutes after each wash. After the final 
wash and spin, the RNA pellet was dried and resuspended in 50 µI H20. The 
RNA was either used immediately for RT-PCR or. stored at -80°C. 
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RT-PCR 
For comparison of the Npro of pestivirus isolates, the region encoding 
the Npro of each isolate was amplified by RT-PCR. Primers were selected 
from conserved genomic regions of BVDV1 (CP7 GenBank accession 
#U63479; NADL GenBank accession #M31182), BVDV2 (890 GenBank 
accession #U18059), and BDV (X818 GenBank accession #AF037405; BD31 
GenBank accession #U70263) that flanked the Npro of each isolate group 
using the Primer 2 program (Scientific and Educational Software, State Line, 
PA, USA). The primers were synthesized by IDT Inc. (Coralville, IA, USA). 
The region encoding the Npro was selectively amplified by adding 2 µI of the 
viral RNA to 98 µI of reverse transcriptase polymerase chain reaction 
(RT/PCR) mix [1x PCR reaction buffer containing 1.75 mM MgCl2, 50 mM 
Tris-HCI pH 9.2, 16 mM (NH4 ) 2S04 (Boehringer Mannheim Corp., 
Indianapolis, IN, USA), 0.1 mM dNTP (Amresco, Solon, OH, USA), 100 pM of 
each primer (forward and reverse), 50 units MMLV reverse transcriptase 
(Gibco/BRL, Gaithersburg, MD, USA), 200 units RNase inhibitor (Promega, 
Madison, WI, USA) and 3 units of Expand High Fidelity polymerase 
(Boehringer Mannheim Corp., Indianapolis, IN, USA)]. The cycling 
conditions were as follows: reverse transcriptase reaction (56°C for 1 hour; 
94°C for 1 minute), PCR reaction (94°C for 15 seconds; 50°C for 30 seconds; 
72°C for 2 minutes) for 35 cycles and one cycle of 72°C for 1 O minutes. 
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Products were visualized on 1% NuSieve 3:1 agarose gels (FMC 
Bioproducts, Rockland, ME, USA) with 0.5 µg/ml ethidium bromide (Amresco, 
Solon, OH, USA) to verify proper fragment sizes. 
Nucleotide sequencing analysis for Npro comparison 
The Npro sequence of each pestivirus isolate was obtained by direct 
sequencing of the PCR products. PCR amplicons were partially purified 
through Microcon-100 microconcentrator spin columns (Amicon, Inc., Beverly, 
MA, USA). To each column, 100 µI of PCR product and 300 µI of H20 were 
added. The columns were centrifuged at 1500 x g for 4 minutes. The 
columns were washed twice with 400 µI of H20 and centrifuged at 1500 x g 
for 4 minutes after each wash. Purified PCR products were recovered by 
inverting the columns and centrifuging at 12,000 x g for 15 seconds. Cycle 
sequencing reactions were performed by adding 25 ng of purified amplicon to 
ThermoSequenase sequencing reaction premix (Amersham Life Science, 
Cleveland, OH, USA). The cycle sequencing reactions were performed by 
one cycle of 94°C for 3 minutes, 98°C for 30 sec; 25 cycles of 98°C for 15 
seconds, 50°C for 1 O seconds, 60°C for 4 minutes; one cycle of 72°C for 1 O 
minutes. Sequencing products were purified with Centri-Sep spin-columns 
(Princeton Separations, Adelphia, NJ, USA). Columns were hydrated with 
800 µI of H20 and vortexed briefly to mix the matrix solution. The columns 
- -~--- - --------------~ 
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were initially centrifuged at 850 x g for 2 minutes. The products from the 
cycle sequencing reactions were added to the column and the columns were 
centrifuged at 850 x g for 3 minutes. The purified sequencing products were 
desiccated by centrifugation under vacuum for 30 minutes without heat. 
Sequencing products were loaded and analyzed on an ABI 373 automated 
DNA sequencer (Applied Biosystems, Forster City, CA, USA). 
Polyacrylamide gels (6%) were used in the automated DNA sequencer. Gels 
were prepared by combining 40 g of ultra-pure urea (Amresco, Solon, OH, 
USA), 9.6 ml of 50% Long Ranger (FMC Bioproducts, Rockland, ME, USA), 
and 9.6 ml of 1 Ox TBE. The volume of the solution was adjusted to 80 ml 
with H20 and the solution was filtered through a 0.2 µcellulose nitrate filter. 
The addition of 45 µI of TEMED (Amresco, Solon, OH, USA) and 400 µI of 
10% ammonium persulfate (Amresco, Solon, OH, USA) initiated 
polymerization of the gel. The resulting sequences were edited and aligned 
using Mac-DNASIS (Hitachi Software Engineering Co., Ltd., San Bruno, CA, 
USA) and MegAlign (DNASTAR, Madison, WI, USA). 
RT-PCR for cloning of Npro 
RT-PCR for the generation of the control Npro PCR amplicon was 
performed using BVDV2-890 specific primers encoding a Barn H I restriction 
site at the 5' end of the insert (genome position 386) and a Xba I restriction 
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site at the 3' end of the insert (genome position 1216) by the same PCR 
protocol listed above. Primer sequences and their respective restriction sites 
are listed in Table 3. BVDV2-890 genomic RNA was used as template for 
the PCR reaction and amplification was performed as described above. 
The resulting PCR product was purified by a Microcon-100 
microconcentrator spin column (Amicon, Inc., Beverly, MA, USA) and 1 µg of 
the product was digested in 50 µI of reaction mix containing 10 units of Bam H 
I (Gibco BRL, Gaithersburg, MD, USA), 10 units of Xba I (Gibco BRL, 
Table 3. Sequences of primers used to generate control NPro insert and for 
site-directed mutagenesis PCR reactions. The restriction sites encoded by 
each primer are underlined. 
I Primer Nucleotide seguence I Restriction site 
386 GCCGCCGGATCCACCATGGAGTTGTTTTCAAATG BamH I 
1216 comp GCCGCCTCTAGACTAGTTCCACTGGGTAATATTC Xbal 
G67V CCTGCCGCGGAAAGTCGACTGCCGG Sa/I 
G67V comp CCGGCAGTCGACTTTCCGCGGCAGG Sa/I 
C69T GGAAAGGTGACACGCGTAGAGGTAATG Mlul 
C69T comp CATTACCTCTACGCGTGTCACCTTTCC Mlul 
H130V GGAAATTATACGTAATCTACATCTGC SnaB I 
H130V comp GCAGATGTAGATTACGTATAATTTCC SnaB I 
C168A GGGTCACCAGCGCTAGCGATGAAGGGAG Nhe I 
C168Acomp CTCCCTTCATCGCTAGCGCTGGTGACCC Nhe I 
S1691 GGGTCACCAGCTGCATCGATGAAGGGAG Gia I 
S1691 comp CTCCCTTCATCGATGCAGCTGGTGACCC Gia I 
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Gaithersburg, MD, USA) and 1 x reaction buffer (10 mM Tris-HCI pH 7.9, 10 
mM MgCl2, 50 mM NaCl, 1 mM OTT) for one hour at 37°C. Plasmid 
pBluescript II KS (Stratagene, La Jolla, CA, USA) was also digested with Barn 
H I and Xba I under the same conditions. The digested products were then 
pooled, phenol/chloroform extracted, ethanol precipitated, and resuspended 
in 15 µI of H20 to which one unit of T4 DNA ligase (Gibco BRL, Gaithersburg, 
MD, USA) and 4 µI of 5x T4 DNA ligase buffer (250 mM Tris-HCI pH 7.6, 50 
mM MgCl2 , 5 mM ATP, 5 mM OTT, 25% polyethylene glycol) were added for 
overnight ligation at 14°C. The ligated plasmid was used to transform 
competent DH5a E. coli cells (Gibco BRL, Gaithersburg, MD, USA) by mixing 
10 µI of ligation reaction and 50 µI of cells and incubation at 4 °C for 30 
minutes. The cells were heat shocked at 42°C for 1 minute. One ml of SOC 
media (Sambrook et al., 1989) was added and the cells and were incubated 
at 37°C for 30 minutes. The cells were plated (100 µI) onto Luria-Bertani 
(LB) agar plates supplemented with 100 µg/ml of ampicillin (Sigma Chemical, 
St. Louis, MO, USA) and 0.8 mg of X-gal (Sigma Chemical, St. Louis, MO, 
USA). The plates were incubated overnight at 37°C. Plates were checked 
for the presence of blue (pBluescript only) and white (pBluescript containing 
insert) colonies. 
45 
Minipreps 
From the incubated plates described above, white colonies were 
picked and grown in 5 ml of liquid LB media supplemented with 100 µg/ml of 
ampicillin overnight. Miniprep reactions were performed to isolate plasmids 
and screen for proper insert size. One ml of bacterial culture was centrifuged 
at 15,000 x g for 30 seconds in a 1.5 ml test tube and the supernatant was 
poured off. The pelleted cells were resuspended in 100 µI of resuspension 
buffer P1 (50 mM Tris-Cl pH 8.0, 10 mM EDTA, 100 µg/ml RNase A), 200 µI 
of lysis buffer P2 (200 mM NaOH, 1 % SOS) was added, and the solution was 
mixed and incubated at room temperature for five minutes. Finally, 150 µI of 
neutralization buffer P3 (3.0 M potassium acetate pH 5.5) was added, the 
solution was mixed and then incubated at room temperature for 15 minutes. 
The solutions were centrifuged at 15,000 x g for 5 minutes and 410 µI of the 
supernatant was transferred to a new tube. The plasmid DNA was 
precipitated by the addition of 500 µI of isopropanol. The resulting solution 
was incubated at room temperature for 15 minutes and then centrifuged at 
15,000 x g for 10 minutes. The supernatant was removed and the DNA 
pellet was resuspended in 75 µI of TE buffer (10 mM Tris-Cl pH 8.0, 1 mM 
EDT A). Plasmids were digested by adding 5 µI of miniprep DNA to a 
reaction mix containing Barn H I and Xba I as described above and incubated 
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at 37°C for one hour. The digestion products were loaded onto a 1 % 
agarose gel containing ethidium bromide to visualize the fragment sizes as 
previously described. Miniprep cultures that resulted in digestion products of 
approximately 830 bp were used for plasmid isolation and for further 
characterization. 
Plasmid isolation 
Plasmids were isolated and purified from the transformed cells by midi-
preps (Qiagen, Valencia, CA, USA). Erlenmeyer flasks (300 ml) containing 
75 ml of LB media with 100 µg/ml ampicillin were inoculated with 100 µI of 
miniprep cultures from above. Cells were grown at 37°C overnight with 
shaking at 250 rpm. The cells were pelleted from the media by centrifuging 
at 5,000 x g for 5 minutes. The cells were resuspended in 5 ml of buffer P1, 
5 ml of buffer P2 was added, the cells were mixed, and incubated at room 
temperature for five minutes. Five ml of buffer P3 was added, mixed, and 
incubated at 4°C for 15 minutes. The resulting solution was centrifuged at 
12,000 x g for 30 minutes and the supernatant was added to the supplied 
QiaTip 100 column that had been equilibrated with 4 ml of buffer QBT (750 
mM NaCl, 50 mM MOPS pH7.0, 15% isopropanol, 0.15% Triton X-100). The 
column was washed twice with 10 ml of buffer QC (1.0 M NaCl, 50 mM 
MOPS pH 7.0, 15% isopropanol) and the plasmid eluted from the column with 
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5 ml of buffer QF (1.25 M NaCl, 50 mM Tris-Cl pH 8.5, 15% isopropanol). 
Plasmid DNA was precipitated by addition of 3.5 ml of isopropanol to the 
eluted plasmid solution and centrifugation at 20,000 x g for 30 minutes. The 
supernatant was removed and the DNA was resuspended in 50 µI of H20. 
Purified plasmids were sequenced to determine T3 promoter position and 
fidelity of the NPro sequence. One plasmid, BS14, was determined to contain 
the correct insert and a sequence identical to that previously reported for 
BVDV isolate 890 (Ridpath and Bolin, 1995). This plasmid was used as a 
control plasmid for the subsequent generation of Npro mutants. 
Site-directed mutagenesis of Npro 
Site-directed mutations were introduced at amino acid positions 67, 69, 
130, 168, and 169 using specific primers listed in Table 3. Each mutation 
created a specific restriction site to verify the substitution of an amino acid. 
In Figure 2, the position of each amino acid substitution with respect to the 
BVDV open reading frame is shown. The pBluescript control plasmid BS14 
was used as template for the site-directed mutational PCR reactions. In 
order to generate inserts containing the desired mutation, the fragments for 
cloning were assembled in two separate reactions. The first reaction used 
primer 386 Barn H I as well as the mutation complement primer. The second 
reaction contained both the mutation primer and the complement primer 1216 
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386 BamH I 
... 
A 5·-~f N T c TE ~ 
.. 
1216 Xba I 
67 69 130 168 169 
B * * * *I* ii i ii 
Sal I Avr II SnaB I Nhe I Cla I 
Figure 2. Illustration of the BVDV open reading frame encoded proteins and 
amino acid mutation positions. (A) Arrangement of BVDV genome, 
beginning with the 5' untranslated region and continuing through the N 
terminal protease (NPro), capsid protein (C), and glycosylated envelope protein 
(Ems). The nucleic acid positions are indicated for the respective protein start 
sites. PCR primers 386 BamH I and 1216 Xba I are shown to illustrate the 
region encoded in plasmid inserts. (B) Amino acid residues that are targeted 
for site-directed mutagenesis are indicated by +. The restriction site that is 
created within each mutation is noted by arrows. 
Xba I. The two fragments were generated by PCR, as described above, 
were partially purified by Microcon-100 (Amicon, Inc., Beverly, MA, USA) 
centrifugation, and digested separately with the restriction enzyme that cut at 
the introduced restriction site. After phenol/chloroform extraction, the two 
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insert fragments were ligated overnight with T4 DNA ligase at 14°C as 
described above. The ligated insert and pBluescript II KS were then digested 
with Bam HI and Xba I and ligated overnight with T4 DNA ligase at 14°C. In 
Figure 3, the site-directed mutagenesis process is shown. The ligated 
plasmids were used to transform competent DH5a E.coli. Cells were grown 
on LB agar plates supplemented with ampicillin and X-gal as described 
above. White colonies were picked from the plates and grown in 5 ml of 
liquid LB media supplemented with ampicillin. These cultures were used for 
miniprep plasmid DNA isolation and screening for 830 bp inserts as described 
above. Cultures that were found to contain proper size inserts were grown in 
75 ml of liquid LB media supplemented with ampicillin and the plasmids were 
isolated and purified by the midi-prep procedure described above. All 
plasmids were sequenced to determine T3 promoter position, fidelity of the 
open reading frame, and the presence of the desired mutation. Standard 
mutation symbols were used, with the first letter representing the original 
amino acid residue, the number indicating the amino acid position, and the 
last letter representing the amino acid that was substituted at this position. 
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PCR reaction #2 
I ~igest internal 
testriction site 
f igate halves 
i Digest ends with Barn H I and Xba I and ligate into pBluescript 
Figure 3. Creation of amino acid substitutions via site-directed mutagenesis. 
Insert segments were amplified by PCR, digested, and ligated. Complete 
inserts were ligated into pBluescript. See text for complete reaction reagents 
and conditions. 
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Error prone PCR 
Additional mutations were introduced into Npro by error prone PCR 
(Cadwell and Joyce, 1992; Ling and Robinson, 1997). The fidelity of the 
PCR reaction was reduced by doubling the Taq DNA polymerase 
(Boehringer Mannheim Corp., Indianapolis, IN, USA) concentration to 5 units, 
increasing the MgCl2 concentration to 7 mM, and decreasing primer 
concentrations to 30 pM each. Primers 386 Barn HI and 1216 Xba I were 
used to amplify the insert containing region from the control plasmid BS14. 
PCR products were visualized on a 1 % agarose gel with ethidium bromide to 
determine product size. PCR reactions were partially purified by Microcon-
100 (Amicon, Inc., Beverly, MA, USA) centrifugation, digested with Barn HI 
and Xba I, cloned into pBluescript II KS, and used to transform DH5a E. coli. 
Transformed cells were plated on LB agar plates supplemented with 
ampicillin and X-gal and incubated overnight. White colonies were picked, 
grown, and plasmids screened by the miniprep procedure. Cultures that 
contained roughly 830 bp inserts were grown for plasmid isolation and 
purification by the midiprep procedure. Plasmids were sequenced to 
determine the location of the mutation, verify that only one amino acid 
substitution per insert was generated, and verify the open reading frame. 
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In vitro translation 
For visualization of the autoproteolytic activity of Npro, the above 
constructed control and mutant plasmids were translated in a cell-free in vitro 
transcription coupled translation reaction using wheat germ lysates (Promega, 
Madison, WI, USA). Transcription was directed from the T3 promoter and 
translation was performed in the presence of [35S] methionine and [35S] 
cysteine. The reactions were assembled by mixing 25 µI of wheat germ 
extract, 2 µI of reaction buffer, 1 µI of T3 RNA polymerase, 1 µI of amino acid 
mixture minus methionine, 2 µI of [35S] methionine, 2 µg of plasmid DNA 
template and water to a final volume of 50 µI. The translation reactions were 
incubated at 30°C for 90 minutes and then treated with 0.2 mg/ml of RNase 
(Boehringer Mannheim Corp. , Indianapolis, IN, USA) for 30 minutes at 30°C. 
Following addition of an equal volume of 2x sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SOS-PAGE) loading buffer (100 mM Tris-
HCI pH6.8, 200 mM OTT, 4% SOS, 0.2g bromophenol blue, 20% glycerol), 
the solutions were denatured by boiling. Translation products were 
visualized by electrophoresis on a 12.5% SOS-PAGE resolving gel [9.3 ml of 
29:1 acrylamide: bis-acrylamide 40% solution (Amresco, Solon, OH, USA), 
11.2 ml of 1 M Tris-HCI pH 8.7, 150 µI of 20% SOS, 7.8 ml of H20, 25 µI 
TEMED (Sigma Chemical, St. Louis, MO, USA) and 100 µI of 10% 
ammonium persulfate] with a 4% stacking gel [1 ml of 29:1 acrylamide: bis-
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acrylamide 40% solution (Amresco, Solon, OH, USA), 1.25 ml of 1 M Tris-HCI 
pH 6.9, 50 µI of 20% SOS, 7.1 ml of H20,-25 µI of TEMED (Sigma Chemical, 
St. Louis, MO, USA) and 50 µI of 10% ammonium persulfate]. Following 
electrophoresis, the gel was fixed in a 60% H20: 30% ethanol: 10% acetic 
acid solution for one hour and dried at 65°C for four hours under vacuum. 
The gel was then exposed overnight at -80°C to X-Omat AR autoradiography 
film (Kodak, Rochester, NY, USA). 
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RESULTS 
Npro sequence comparison 
DNA sequences of NP10 representing five isolates each of BVDV1, 
BVDV2, BDV, and CSFV were obtained. The NPro DNA sequences were 
converted into amino acid sequences for sequence comparison. The amino 
acid sequences representing NP10 of 20 pestivirus isolates were aligned and 
conserved regions were identified. The results are displayed in Figure 4. 
The overall sequence identity among the 20 pestivirus isolates was 61.7%. 
The sequence identity among the five BVDV1 isolates was 85.9%, among the 
five BVDV2 isolates was 81.1 %, among the five BDV isolates was 93.0%, and 
among the five CSFV isolates was 88.1 %. There were many conserved 
regions throughout the NPro, but significant regions (three or more amino 
acids) included amino acids: 1-3; 9-12; 40-49; 67-70; 78-82; 84-87; 95-99; 
101-104; 119-123; 161-164. Conserved amino acid residues of NP10 , as 
revealed by this alignment, were selected as targets for site-directed 
mutagenesis. 
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Figure 4. Comparison of amino acid sequences of pestivirus Npro. Five 
isolates each of CSFV, BDV, BVDV1, and BVDV2 are compared. 
Conserved amino acids are indicated within each sequence by periods(.). 
Areas of conservation are indicated above the consensus sequence by black 
boxes. The amino acids that were mutated in this study are indicated by 
stars ( *) above the conserved boxes. 
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Colony screening and mutant selection 
Site-directed mutagenesis resulted in the creation of five plasmids 
containing single amino acid substitutions in NPro. The resulting plasmids 
were designated according to the amino acid substitution that was created in 
Npro: G67V, C69T, H130V, C168A, and S1691. In addition, a plasmid 
containing a 19 amino acid deletion within the NPro from position 69 to 88 was 
isolated and designated 69DEL. Error prone PCR generated ten plasmids 
containing single amino acid substitutions in NPro and were designated: L8F, 
N28S, K46R, L63P, N75Y, S124C, Y129C, C138R, V155L and N157S. In 
addition, three plasmids containing two amino acid substitutions per Npro 
coding region were identified and designated as K16R - I 135V, Q50R -
M111V, and V121A-1133S. 
In vitro translation 
In vitro translation products of the control and mutant plasmid 
constructs were separated on 12% SOS-PAGE gels. The gels were dried 
and exposed overnight to autoradiograph film. The resulting gel images are 
displayed in Figures 5 and 6. The control plasmid BS14 translation products 
were 20 kDa (Npro) and 14 kDa (capsid) in size, demonstrating that the 
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Figure 5. Autoradiograph of in vitro translation products from plasmid constructs 
generated from site-directed mutagenesis of N pro. The amino acid substiutions 
that were created at selected residues are indicated. A 37 kDa precursor protein, 
containing N pro capsid, and truncated Ems, was observed in each translation. 
The self-cleavage of NPro generated a 20kDa protein. Absence of a 20 kDa band 
indicates that the amino acid substitution prevent~d self-cleavage of N pro_ 
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Figure 6. Autoradiograph of in vitro translation products of plasmid 
constructs generated by error prone PCR mutagenesis of Npro . 
The amino acid substitutions that were created are indicated. A 37 
kDa precursor protein containing Npro, capsid, and truncated pns, 
was observed in each translation. The self-cleavage of Npro 
generated a 20 kDa protein. Absence of a 20 kDa band indicates 
that the amino acid substitution prevented self-cleavage of Npro. 
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unaltered Npro possessed autocatalytic activity. A faint 37 kDa precursor 
protein product was also observed representing the uncleaved NPro, C, and 
truncated Ems. Plasmid H130V translation products were 20 kDa and 14 kDa 
in size, with a faint 37 kDa precursor protein band also observed. The 
cleavage patterns of the H 130V translated proteins are similar to the cleavage 
patterns of the control plasmid BS14 translated proteins. Self-cleavage of 
Npro (20 kDa) was not detected in translation products from plasmids G67V, 
C69T, and 69DEL, despite producing prominent 37 kDa precursor proteins. 
The shift in size of the precursor band from 69DEL can be attributed to the 19 
amino acid deletion. Translated Npro from plasmids C168A and S1691 
partially cleaved. Faint Npro and C bands were observed, but a prominent 
precursor band was also produced by translation of both plasmids C168A and 
S1691. 
Translation products from error prone PCR mutation plasmids LBF, 
N28S, K46R, N75Y V155L, and V121A- 1133S produced cleavage patterns 
similar to plasmid BS14. The error prone PCR mutation clones L63P, 
S 124C, and Y129C did not generate a 20 kDa protein (NPro) but a 37 kDa 
precursor protein was produced in each translation reaction. Partial 
cleavage of Npro and C was observed with translation products from plasmids 
C138R, N157S, K16R - 1135V, and QSOR - M111V. Table 4 displays a 
summary of the NPro cleavage patterns. 
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Table 4. Npro amino acid substitutions were generated by site-directed 
mutagenesis and error prone PCR. The mutated NPro encoding regions were 
cloned into pBluescript for in vitro translation. Cleavage of Npro from the 
precursor protein was obseNed by SOS-PAGE gel separation. 
Mutation Npro cleava e Mutation Npro cleava e 
LBF + H130V + 
N28S + C138R +/-
K46R + V155L + 
L63P N157S +/-
G67V C168A +/-
C69T S1691 +/-
69 DEL K16R - 1135V +/-
N75Y + Q50R - M111V +!-
S124C V121A- 1133S + 
Y129C 
+ indicates NPro self-cleavage from precursor protein. 
- indicates that Npro self-cleavage was prevented. 
+/-indicates that Npro self-cleavage was partially prevented. 
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DISCUSSION 
The work described in this study was performed to further ~haracterize 
the catalytic unit of the amino terminal protease (Npro) of BVDV. This 
hopefully will lead to the determination of the function of this protease. The 
catalytic unit is responsible for the self-cleavage of the protease. Catalytic 
units are composed of amino acid residues that fold into a conformationally 
active site and function in peptide bond cleavage. Catalytic dyads, triads, 
and tetrads have been reported for both cellular and viral-encoded proteases 
(Rawlings and Barrett, 1993). These catalytic units have been used to 
classify proteases into families of serine, cysteine and aspartic acid proteases 
(Rawlings and Barrett, 1993). 
Amino acid comparisons of cellular and viral-encoded proteases with 
Npro had previously identified some sequence homology between papain-
related cysteine proteases and Npro (Stark et al., 1993; Rumenapf et al., 
1998). In these previous studies, several conserved amino acids were 
mutated to identify catalytic residues of Npro but identification of the catalytic 
unit was not determined (Wiskerchen et al., 1991; Rumenapf et al., 1998). 
In this study, the Npro sequence of 20 pestivirus isolates was compared 
to identify conserved regions that could represent functional amino acids of 
NPro (Figure 4). This comparison identified motifs suggestive of both cysteine 
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and serine proteases. Conserved cysteine (Cys) and histidine (His) residues 
were identified in our NPro sequence comparison. The spatial arrangement of 
some of these Cys and His residues resembled a cysteine protease catalytic 
unit. Sequence comparison also revealed conserved His, aspartic acid 
(Asp), and serine (Ser) residues that suggested possible catalytic amino acids 
of a serine protease. In addition, a glycine - serine - aspartic acid - glycine 
(Gly123- Ser124- Asp125- Gly126) motif in Npro was found to be similar to the 
Gly- Asp- Ser- Gly motif found in many serine proteases (Rawlings and 
Barrett, 1994). 
Based on amino acid conservation of Npro, site-directed mutations were 
created at residues Gly67, Cys69, His130, Cys168, and Ser169 of Npro. 
Amino acid substitutions at Gly67 and Cys69 prevented self cleavage of Npro. 
Gly67 was conserved among all pestivirus isolates compared in this study, 
indicating that it may be a component of the catalytic unit. Gly67 was not 
suspected as a possible catalytic residue in previous studies. The prevention 
of Npro cleavage by a Cys69 substitution was recently reported (ROmenapf et 
al., 1998) and a Cys69 substitution in our study also prevented cleavage of 
Npro. Data presented in this study confirms that Cys69 is required for NPro 
cleavage. An additional Npro mutation created by site-directed mutagenesis 
resulted in the deletion of 19 amino acids after Cys69. This deletion 
prevented self-cleavage of NPro. A deletion of amino acids may render the 
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protease non-functional because of folding failure, altered conformation, or 
loss of functional residues. 
Amino acid His130 was conseNed among all pestivirus isolates 
compared in this study. In addition, His130 was found in a region containing 
two other conseNed amino acids. Translation data indicated that an amino 
acid substitution at His130 did not prevent self-cleavage of NPro. A previous 
study also reported that substitution of His130 failed to prevent cleavage of 
Npro (RUmenapf et al., 1998). The data presented here confirms the lack of 
involvement of His130 in the catalytic unit of Npro. 
Site-directed mutations at amino acids Cys168 and Ser169 resulted in 
partial prevention of NPro self-cleavage. The amino acid substitution at 
Cys168, the C-terminal end of Npro, was expected to eliminate Npro cleavage 
because of alteration of the cleavage site. Proteases have been reported to 
display specificity for their cleavage site and alteration of the C-terminal 
amino acid of many proteases has been reported to eliminate autoproteolytic 
cleavage (Babe and Craik, 1997; Wellink and van Kammen, 1988). The 
amino acid substitution of Ser169, the N-terminal residue of the capsid 
protein, also resulted in decreased Npro cleavage. The results from 
translation of plasmids C168A and S1691 suggest that self-cleavage is 
independent of the amino acids contained at the cleavage site. An additional 
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mechanism, such as distance of the C-terminal end of the protease from the 
active site, may be responsible for selection of the cleavage site. 
A second approach to identify functional amino acids involved the use 
of error-prone PCR to generate additional amino acid substitutions. Error-
prone PCR generated amino acid substitutions at residues Leu63, Ser124, 
and Tyr129 that prevented self-cleavage of NPro. Leu63 and Tyr129 were 
found to be conserved among the 20 pestivirus isolates compared in this 
study. Assuming these amino acids are conserved among all pestiviruses, 
mutation of these residues would be more likely to eliminate autoproteolytic 
cleavage. Description of catalytic activity associated with leucine or tyrosine 
residues was not found in the available literature. Ser124 was found to be 
conserved among 19 of 20 pestiviruses compared in this study. The CSFV 
isolate Glentorf did not contain a conserved serine residue, but instead 
contained an asparagine residue at this position. It is possible that Ser124 is 
a catalytic amino acid residue of Npro, suggestive of a serine protease. 
However, previous studies reported that substitution of Ser124 did not affect 
cleavage (Wiskerchen et al., 1991 ). 
Error prone PCR resulted in the creation of amino acid substitutions at 
residues Leu8, Asn28, Lys46, Asn75, Val121, lle133, and Val155 that did not 
prevent NPro cleavage. From the above listed mutations that did not prevent 
self-cleavage of NPro, only Lys46 represents a conserved amino acid among 
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all pestivirus isolates compared in this study. Mutation of conserved residues 
was predicted to diminish or eliminate cleavage of NPro, but the mutation at 
Lys46 did not support this hypothesis. Lys46 is located within a conserved 
motif of ten amino acids (Figure 4). This motif contains more sequential 
conserved amino acids than any other region found in the sequence 
comparison of Npro and could represent a portion of the catalytic pocket of 
Npro. Additional studies are needed to determine the importance of this 
conserved motif. 
This study has demonstrated that substitutions amino acids Leu63, 
. Gly67, Ser124, and Tyr129 prevent self-cleavage of Npro. Data presented 
here supports a previous report that mutation of amino acid Cys69 also 
prevents NPro self-cleavage (Rumenapf et al., 1998). Previous studies also 
found that amino acids Glu22 and His49 (Rumenapf et al., 1998) and His40 
and Trp164 (Wiskerchen et al., 1991) were necessary for NP10 self-cleavage. 
However, those studies were not able to identify the catalytic unit of NPro. 
The data presented in this study indicates that NPro resembles the 
serine protease chymotrypsin. In addition, this study proposes that the 
His49/Asp68/Ser124 catalytic triad of NPro is similar to the His/Asp/Ser 
catalytic triad of chymotrypsin. The majority of viral proteases that have 
been characterized are either cysteine or serine proteases. In this study, 
mutations introduced at both cysteine and serine residues prevented 
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cleavage of NPr0 • In addition, mutations at other amino acids indicated other 
possible members of the catalytic unit. A previous study found that His49 
was essential for NPro cleavage (Rumenapf et al. , 1998). This study proposes 
that His49 is the first member of the catalytic triad. The second member of 
the proposed catalytic triad, aspartic acid, is present at amino acid position 
68. Although this amino acid was not selected for mutation, mutations at 
both Gly67 and Cys69 eliminated cleavage of Npro. These mutations flanked 
Asp68 and may have disrupted the catalytic function of Asp68. The third 
member of the proposed catalytic triad is Ser124. Results of this study 
demonstrated that mutation of Ser124 resulted in loss of NPro cleavage. The 
amino acids of the His49/Asp68/Ser124 catalytic triad fold into a three-
dimensional catalytic unit to cleave NPro from C. 
Additional support for the newly proposed protease characterization 
and catalytic unit identification is provided by a conserved motif around the 
active Ser124 residue. It has been reported that glycine residues are 
conserved near the catalytic serine residue of serine proteases. In addition, 
a conserved Gly-Asp-Ser-Gly motif is found in many serine proteases, 
although slight variations exist (Rawlings and Barrett, 1994). A similar 
conserved motif, Gly-Ser-Asp-Gly, was identified during the sequence 
analysis of NPro in this study. Mutation of Tyr129, adjacent to this Gly-Ser-
Asp-Gly conserved motif, eliminated self-cleavage of NPro. This amino acid 
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substitution may have altered the structural conformation of the Ser124 motif 
that is essential for Npro self-cleavage. 
Future characterization of the Npro autoprotease by additional 
mutagenic studies or 3-dimensional structural analysis will confirm whether 
Npro is a chymotrypsin-like serine protease. The findings presented here 
provide a greater understanding of Npro and will aid in future pestivirus and 
viral protease research. 
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GENERAL CONCLUSIONS 
This study compared the N-terminal protease (NPro) of BVDV type 1 
and 2, CSFV, and BDV in order to identify conserved amino acid residues. 
This analysis revealed conserved regions that were compared to amino acid 
sequences of viral and cellular proteases to identify catalytic amino acids and 
potential catalytic units. Amino acid sequence analysis of NPro revealed 
conserved cysteine (Cys) and histidine (His) residues, suggestive of a 
cysteine protease. Amino acid sequence analysis also revealed conserved 
His, aspartic acid (Asp), and serine (Ser) residues, suggestive of a 
chymotrypsin-like serine protease. A conserved glycine- serine- aspartic 
acid- glycine motif was discovered that also suggested similarity to the serine 
protease chymotrypsin . 
Both site-directed mutagenesis and error prone PCR resulted in amino 
acid substitutions within NPro. These mutated Npro coding regions were 
translated in vitro and the effect of the amino acid substitution on NPro self-
cleavage was determined. This study demonstrated that mutations at amino 
acids Leu63, Gly67, Cys69, Ser124, and Tyr129 prevented self-cleavage of 
the NPro autoprotease. This study proposes that amino acids His49, Asp68, 
and Ser124 represent the catalytic triad of NPro. This catalytic triad resembles 
that of the serine protease chymotrypsin . Although a definitive protease 
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characterization cannot be made, the data presented in this study provides a 
better understanding of the autoproteolytic activity of NPro. 
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